Influence of dual blockade of the renin-angiotensin system on thirst in hemodialysis patients

Nephron - Clinical Practice

Volumn 112, Issue 4, 2009, Pages

  Masajtis Zagajewska, Anna ^a   Nowicki, Michał ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensin receptor antagonists; Chronic hemodialysis therapy; Xerostomia

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; LOSARTAN; PARAFFIN; PLACEBO; POTASSIUM;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS; DOUBLE BLIND PROCEDURE; ELECTROLYTE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; MASTICATION; MEAN ARTERIAL PRESSURE; MORNING DOSAGE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALIVATION; SINGLE DRUG DOSE; STIMULATION; THIRST; TREATMENT DURATION; VISUAL ANALOG SCALE; WEIGHT GAIN; XEROSTOMIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CROSS-OVER STUDIES; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PLACEBO EFFECT; RENAL DIALYSIS; RENIN-ANGIOTENSIN SYSTEM; THIRST; TREATMENT OUTCOME; WEIGHT GAIN; XEROSTOMIA;

EID: 67449122958     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224790     Document Type: Article

References (35)

1. Oldenburg B, Macdonald GJ, Perkins RJ: Factors influencing excessive thirst and fluid intake in dialysis patients. Dial Transplant 1988; 17: 21-23.
2. Giovannetti S, Barsotti G, Cupist A: Dipsogenic factors operating in chronic uremics on maintenance hemodialysis. Nephron 1994; 66: 413-420.
3. Van Stone J: Controlling thirst in dialysis patients. Semin Dial 1996; 9:47-50.
4. Yamamoto T, Shimizu M, Morioka M, Kitano M, Wakabayashi H, Aizawa N: Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure. JAMA 1986; 256: 604-608.
5. Rogers PW, Kurtzman NA: Renal failure, uncontrollable thirst and hyperreninemia: cessation of thirst with bilateral nephrectomy. JAMA 1973; 225: 1236-1238.
6. Brown JJ, Curtis JR, Lever AF: Plasma rennin concentration and the control of blood pressure in patients on maintenance hemodialysis. Nephron 1969; 6: 329-349.
7. Fitzsimons JT: The Physiology of Thirst and Sodium Appetite. Cambridge, Cambridge University Press, 1979, vol 35, pp 1-121.
8. Oldenburg B, Macdonald G, Shelley S: Controlled trial of enalapril in patients with chronic fluid overload undergoing dialysis. Br Med J 1998; 296: 1089-1091.
9. Kuriyama S, Tomonari H, Osamu S: Effects of cilazapril on hyperdipsia in hemodialyzed patients. Blood Purif 1996; 14: 35-41.
10. Kirch W, Horn B, Schweizer J: Comparison of angiotensin II receptor antagonists. Eur J Clin Invest 2001; 31: 698-706.
11. Bots C, Brand H, Veerman E: Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int 2004; 66; 1662-1668.
12. Navazesh M, Christensen C, Brightman V: Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992; 71: 1363-1369.
13. Heidbreder E, Bahner U, Hes M: Regulation of thirst in end-stage kidney insufficiency. Klin Wochenschr 1990; 68: 1127-1133.
14. Wirth JB, Folstein MF: Thirst and weight gain during maintenance hemodialysis. Psychosomatics 1982; 23: 1125-1134.
15. Levin A, Goldstein MB: The benefits and side effects of ramped hypertonic sodium dialysis. J Am Soc Nephrol 1996; 7: 242-246.
16. Dominic SC, Ramachandran S, Soniach S: Quenching the thirst in dialysis patients. Nephron 1996; 73: 597-600.
17. Sherman RA, Cody RP, Rogers ME: lnterdialytic weight gain and nutritional parameters in chronic hemodialysis patients. Am J Kidney Dis 1995; 25: 579-583.
18. Virga G, Mastrosimone S, Amici G: Symptoms in hemodialysis patients and their relationship with biochemical and demographic parameters. Int J Artif Organs 1998; 21: 788-793.
19. Welch JL: Hemodialysis patient beliefs by stage of fluid adherence. Res Nurs Health 2001; 24: 105-112.
20. Hamad A, Khosrovaneh A, Gupta S, Fazal S, Thomas M, Feinfeld DA: Lack of effect of long-term use of angiotensin-converting enzyme inhibitors by hemodialysis patients on thirst and fluid weight gain. Ren Fail 2002; 24: 461-466.
21. Rostoker G, Griuncelli M, Benmaadi A: Candesartan cilexetil on regular hemodialysis: Inability to reduce excessive thirst, but good tolerance and efficacy in hypertensive patients. Ren Fail 2006; 28: 283-286.
22. Saracho R, Martin-Malo A, Martinez I, Aljama P, Montenegro J: Evaluation of the Losartan in Hemodialysis (ELHE) Study. Kidney Int Suppl 1998; 68:S125-S129.
23. Porth CM, Erickson M: Physiology of thirst and drinking: implication for nursing practice. Heart Lung 1992; 21: 273-282.
24. Welch JL: Development of the thirst distress scale. Nephrol Nurs J 2002; 29: 337-342.
25. Brunstrom JM: Effects of mouth dryness on drinking behavior and beverage acceptability. Physiol Behav 2002; 76: 423-429.
26. Martinez-Vea A, Garcia D, Gaya J: Abnormalities of thirst regulation in patients with chronic renal failure on hemodialysis. Am J Nephrol 1992; 12: 73-79.
27. Kao CH, Hsieh JF, Tsai SC: Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis 2000; 36: 1110-1114.
28. Kho HS, Lee SW, Chung SC, Kim YK: Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with endstage renal disease undergoing hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 1999; 88: 316-319.
29. Gavalda C, Bagan J, Scully C: Renal hemodialysis patients: oral, salivary, dental and periodontal findings in 105 adult cases. Oral Dis 1999; 5: 299-302.
30. Bayraktar G, Kazancioglu R, Bozfakioglu S, Ecder T, Yildiz A, Ark E: Stimulated salivary flow rate in chronic hemodialysis patients. Nephron 2002; 91: 210-214.
31. Bayraktar G, Kazancioglu R, Bozfakioglu S, Yildiz A, Ark E: Evaluation of salivary parameters and dental status in adult hemodialysis patients. Clin Nephrol 2004; 62: 380-383.
32. Turner MD, Ship JA: Dry mouth and its effects on the oral health of elderly people. J Am Dent Assoc 2007; 138: 15S-20S.
33. Thomson WM, Chalmers JM, Spencer AJ, Slade GD: Medication and dry mouth: findings from a cohort study of older people. J Public Health Dent 2000; 60: 12-20.
34. Bomback AS, Klemmer PJ: The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 2007; 3: 486-492.
35. Sreebny LM, Valdini A, Yu A: Xerostomia. II. Relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol 1989; 68: 419-427.